Skip to content
Colorectal Cancer Clinical Trials

Detroit, Michigan

Colorectal cancer clinical trials in Detroit, MI

35 colorectal cancer studies are recruiting participants at sites in Detroit as of November 16, 2026, according to ClinicalTrials.gov. Colorectal Cancer Clinical Trials can help you understand your options and connect with a study team.

Call (888) 385-9581
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Detroit at a glance

  • 35 studies are recruiting at a site in Detroit.
  • By phase: Phase 1 (12), Phase 1/2 (5), Phase 2 (4), Phase 2/3 (1), Phase 3 (6), No phase (6), Observational (1). Studies of devices and behavioral approaches have no phase.
  • By sponsor: industry (23), university, hospital or other (11), government (1).
  • Most recent update to one of these records: November 16, 2026.

Studies recruiting in Detroit

Basic details from each study's public record (the 30 most recently updated of 35). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    GlaxoSmithKline
    Study site
    GSK Investigational Site
    Registry record
    NCT07213609 · updated
  2. A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Astellas Pharma Global Development, Inc.
    Study site
    Barbara Ann Karmanos Cancer Center
    Registry record
    NCT07488676 · updated
  3. A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    IDEAYA Biosciences
    Study site
    Karmanos Cancer Institute
    Registry record
    NCT07503808 · updated
  4. The Vanguard Study: Testing a New Way to Screen for Cancer

    • No phase
    • Ages 45 to 75
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study sites
    Henry Ford Hospital · Henry Ford Medical Center - Detroit Northwest
    Registry record
    NCT06995898 · updated
  5. Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    SWOG Cancer Research Network
    Study site
    Henry Ford Health Saint John Hospital
    Registry record
    NCT07018869 · updated
  6. Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Summit Therapeutics
    Registry record
    NCT07228832 · updated
  7. FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Oncolytics Biotech
    Study site
    Karmanos Cancer Institute
    Registry record
    NCT07446322 · updated
  8. Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

    • Phase 2/3
    • Ages 18 and older
    • All sexes
    Sponsor
    NRG Oncology
    Study site
    Henry Ford Health Saint John Hospital
    Registry record
    NCT05174169 · updated
  9. Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

    • Observational
    • Ages 40 to 75
    • All sexes
    Sponsor
    Alliance for Clinical Trials in Oncology
    Study sites
    Henry Ford Health Saint John Hospital · Henry Ford Hospital
    Registry record
    NCT05334069 · updated
  10. A Study of LY4257496 in Participants With Cancer (OMNIRAY)

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Eli Lilly and Company
    Study site
    Barbara Ann Karmanos Cancer Institute
    Registry record
    NCT07114601 · updated
  11. A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Eli Lilly and Company
    Study site
    Barbara Ann Karmanos Cancer Institute
    Registry record
    NCT07213791 · updated
  12. Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays

    • No phase
    • Ages 18 and older
    • All sexes
    Sponsor
    Alliance for Clinical Trials in Oncology
    Study site
    Henry Ford Health Saint John Hospital
    Registry record
    NCT07283939 · updated
  13. Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Alliance for Clinical Trials in Oncology
    Study site
    Henry Ford Hospital
    Registry record
    NCT05673148 · updated
  14. Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Sairopa B.V.
    Study site
    Henry Ford Cancer Institute
    Registry record
    NCT05856981 · updated
  15. A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Janssen Research & Development, LLC
    Study site
    Henry Ford Hospital
    Registry record
    NCT06662786 · updated
  16. A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Janssen Research & Development, LLC
    Study site
    Henry Ford Hospital
    Registry record
    NCT06750094 · updated
  17. Family Communications After Genetic Testing

    • No phase
    • Ages 18 and older
    • All sexes
    Sponsor
    Alliance for Clinical Trials in Oncology
    Study site
    Henry Ford Health Saint John Hospital
    Registry record
    NCT07143487 · updated
  18. A Study to Investigate the Safety and Efficacy of KQB368 as Monotherapy in Participants With Advanced Solid Malignancies

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Kumquat Biosciences Inc.
    Study site
    Karmanos Cancer Institute
    Registry record
    NCT07542704 · updated
  19. A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    BioNTech SE
    Study site
    Karmanos Cancer Institute
    Registry record
    NCT07186842 · updated
  20. KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Kura Oncology, Inc.
    Study site
    Henry Ford Health System
    Registry record
    NCT06026410 · updated
  21. Colonoscopy vs Stool Testing for Older Adults With Colon Polyps

    • No phase
    • Ages 65 to 82
    • All sexes
    Sponsor
    Dartmouth-Hitchcock Medical Center
    Study site
    Henry Ford
    Registry record
    NCT05612347 · updated
  22. Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Exelixis
    Study sites
    Exelixis Clinical Site #13 · Exelixis Clinical Site #65
    Registry record
    NCT05176483 · updated
  23. A Phase 1/1b Study of IAM1363 in HER2 Cancers

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Iambic Therapeutics, Inc
    Study site
    Henry Ford Cancer Institute
    Registry record
    NCT06253871 · updated
  24. A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Marengo Therapeutics, Inc.
    Study site
    Karmanos Cancer Institute
    Registry record
    NCT05592626 · updated
  25. A Study of ASP1002 in Adults for Treatment of Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Astellas Pharma Global Development, Inc.
    Study site
    Henry Ford Hospital
    Registry record
    NCT05719558 · updated
  26. Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    MOMA Therapeutics
    Registry record
    NCT06974110 · updated
  27. A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Coherus Oncology, Inc.
    Study site
    Henry Ford Health System
    Registry record
    NCT06657144 · updated
  28. Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Endevica Bio
    Study site
    Karmanos Cancer Center
    Registry record
    NCT06937177 · updated
  29. Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Canadian Cancer Trials Group
    Study site
    Henry Ford Hospital
    Registry record
    NCT06205485 · updated
  30. Efficacy and Safety of the CG-100 Intraluminal Bypass Device

    • No phase
    • Ages 22 to 70
    • All sexes
    Sponsor
    Colospan Ltd.
    Study site
    Henry Ford Health System
    Registry record
    NCT04184973 · updated

Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in Detroit, MI on ClinicalTrials.gov.

Ask about studies near Detroit

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

More locations in Michigan

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

Colorectal Cancer Clinical Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 385-9581

or send a short form

How should we reach you?

Call